- Document2009.-Weighing Benefits and Risks the FDA's Review of Prasugreltéléversé partristan9454
- Document2009.Prasugrel in Clinical Practice..téléversé partristan9454
- Document2009.-Prasugrel in Clinical Practicetéléversé partristan9454
- Document2009.- Weighing Benfits and Risk...téléversé partristan9454
- Document2009.- Prasugrel Stemi Subgroup Analysis.autor's Replytéléversé partristan9454
- Document2009.- Prasugrel Stemi Subgroup Analysistéléversé partristan9454
- Document2009.- Effect of the Novel Thienopyridine Prasugrel....téléversé partristan9454
- Document2008.-The Use of the VerifyNow P2Y12 Point-Of-care Device to Monitortéléversé partristan9454
- Document2008.Prasugrel...Acute Coronary Syndromestéléversé partristan9454
- Document2008.-Prasugrel Achieves Greater and Faster P2Y12..téléversé partristan9454
- Document2008.-Bleeding Risks With Pasugre.....téléversé partristan9454
- Document2008. Prasugrel.....Patients With Acute Coronary.téléversé partristan9454
- Document2008. Intensive Anti Platelet ... Prasugreltéléversé partristan9454
- Document2007.-A Comparison of the Anti Platelet Effects of Prasugrel..téléversé partristan9454
- Document2009.- Stroke Prevention in Atrial Fibrillation....téléversé partristan9454
- Document2009.- Cutaneous Blodd Filled Vesicles on Idraparinuxtéléversé partristan9454
- Document2009.- Comparison of Idraparinux With Vitamin Ktéléversé partristan9454
- Document2007.-High Affinity Interaction Between a Synthetic, Highly Negatively Charged..téléversé partristan9454
- Document2007.-Agents to Control Bleeding Show Promisetéléversé partristan9454
- Document2005.-Reversal of a Potent Investigational Anticoagulant Idraparinux With Recombinant Factor VIIa.téléversé partristan9454
- Document2005.Reversal Investigational Anticoagulan Idraparinux...téléversé partristan9454
- Document2004.Oligosaccharides...téléversé partristan9454
- Document2003.Synthetic Pentasaccharides...téléversé partristan9454
- DocumentShort- And Long-Acting Synthetic Pent a Sac Char Idestéléversé partristan9454
- Document2009.- The Pharmacokinetics of Idraparinux, A Long-Acting Indirect Factor Xa Inhibitor Population Pharmacokinetic Analysis From Phase III Clinical Trials.téléversé partristan9454
- Document2006.-Thrombocytopenia Associated With the Use ...téléversé partristan9454
- Document2006.-Frequency and Management of Thrombocytopenia...téléversé partristan9454
- Document2006.-Abciximab Associated Thrombocytopenia...téléversé partristan9454
- Document2005.-Immune Thrombocytopenia Caused by Glycoprotein....téléversé partristan9454
- Document2004.-Repetitive Profound Thrombocytopenia After Treatment With Tirofiban a Case Report.téléversé partristan9454
- Document2009.-First Report of Tirofiban-Induced Anemia (Found in Combination With Severe Thrombocytopeniatéléversé partristan9454
- Document2002.-Acute Thrombocytopenia After Treatment With Tirofiban or Eptifibatide is a2002.téléversé partristan9454
- Document2006.-Thrombocytopenia Associated With the Use ...téléversé partristan9454
- Document2006.-Frequency and Management of Thrombocytopenia...téléversé partristan9454
- Document2006.-Abciximab Associated Thrombocytopenia...téléversé partristan9454
- Document2005.-Immune Thrombocytopenia Caused by Glycoprotein....téléversé partristan9454
- Document2004.-Repetitive Profound Thrombocytopenia After Treatment With Tirofiban a Case Report.téléversé partristan9454
- Document2002.-Acute Thrombocytopenia After Treatment With Tirofiban or Eptifibatide is a2002.téléversé partristan9454
- Document2009.-First Report of Tirofiban-Induced Anemia (Found in Combination With Severe Thrombocytopeniatéléversé partristan9454
- Document1.-BISTRO Itéléversé partristan9454
- Document1.-BISTRO Itéléversé partristan9454